Interaction of the double-strand break repair kinase DNA-PK and estrogen receptor-α

Molecular Biology of the Cell

Volumn 21, Issue 9, 2010, Pages 1620-1628

  Medunjanin, Senad ^a   Weinert, Sönke ^a   Schmeisser, Alexander ^a   Mayer, Doris ^b   Braun Dullaeus, Ruediger C ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA BREAK REPAIR KINASE; ESTROGEN RECEPTOR ALPHA; PROTEASOME; PROTEIN KINASE; SERINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; STIMULATION;

ANIMALS; ANTIGENS, NUCLEAR; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CHROMONES; COS CELLS; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MORPHOLINES; PHOSPHORYLATION; PROTEIN BINDING; RNA INTERFERENCE; UBIQUITIN;

EID: 77951746652     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-08-0724     Document Type: Article

References (43)

1. Anderson, C. W. and Lees-Miller, S. P. (1992). The nuclear serine/threonine protein kinase DNA-PK. Crit. Rev. Eukaryot. Gene Expr. 2, 283-314.
2. Arnold, S. F., Obourn, J. D., Yudt, M. R., Carter, T. H., and Notides, A. C. (1995). In vivo and in vitro phosphorylation of the human estrogen receptor. J. Steroid Biochem. Mol. Biol. 52, 159-171.
3. Augereau, P., Miralles, F., Cavailles, V., Gaudelet, C., Parker, M., and Rochefort, H. (1994). Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol. 8, 693-703.
4. Blunt, T. et al. (1995). Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80, 813-823.
5. Carter, T., Vancurova, I., Sun, I., Lou, W., and DeLeon, S. (1990). A DNA-activated protein kinase from HeLa cell nuclei. Mol. Cell. Biol. 10, 6460-6471.
6. Castoria, G., Migliaccio, A., Bilancio, A., Di Domenico M., de Falco, A., Lombardi, M., Fiorentino, R., Varricchio, L., Barone, M. V., and Auricchio, F. (2001). PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20, 6050-6059. (Pubitemid 33049280)
7. Collis, S. J., DeWeese, T. L., Jeggo, P. A., and Parker, A. R. (2005). The life and death of DNA-PK. Oncogene 24, 949-961.
8. Deroo, B. J.. and Korach, K. S. (2006). Estrogen receptors and human disease. J. Clin. Invest. 116, 561-570.
9. Dvir, A., Stein, L. Y., Calore, B. L., and Dynan, W. S. (1993). Purification and characterization of a template-associated protein kinase that phosphorylates RNA polymerase II. J. Biol. Chem. 268, 10440-10447.
10. Feldmann, H. and Winnacker, E. L. (1993). A putative homologue of the human autoantigen Ku from Saccharomyces cerevisiae. J. Biol. Chem. 268, 12895-12900.
11. Gaben, A. M., Saucier, C., Bedin, M., Redeuilh, G., and Mester, J. (2004a). Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase. Mol. Endocrinol. 18, 2700-2713.
12. Gaben, A. M., Saucier, C., Bedin, M., Redeuilh, G., and Mester, J. (2004b). Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase. Mol. Endocrinol. 18, 2700-2713.
13. Giamarchi, C., Solanas, M., Chailleux, C., Augereau, P., Vignon, F., Rochefort, H., and Richard-Foy, H. (1999). Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines. Oncogene 18, 533-541. (Pubitemid 29060629)
14. Giffin, W., Kwast-Welfeld, J., Rodda, D. J., Prefontaine, G. G., Traykova-Andonova, M., Zhang, Y., Weigel, N. L., Lefebvre, Y. A., and Hache, R. J. (1997). Sequence-specific DNA binding and transcription factor phosphorylation by Ku Autoantigen/DNA-dependent protein kinase. Phosphorylation of Ser-527 of the rat glucocorticoid receptor. J. Biol. Chem. 272, 5647-5658.
15. Goldszmid, R. S., Idoyaga, J., Bravo, A. I., Steinman, R., Mordoh, J., and Wainstok, R. (2003). Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J. Immunol. 171, 5940-5947. (Pubitemid 37467212)
16. Grisouard, J., Medunjanin, S., Hermani, A., Shukla, A., and Mayer, D. (2007). Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor. Mol. Endocrinol. 21, 2427-2439.
17. Hah, Y. S., Lee, J. H., and Kim, D. R. (2007). DNA-dependent protein kinase mediates V(D)J recombination via RAG2 phosphorylation. J. Biochem. Mol. Biol. 40, 432-438.
18. Hartley, K. O., Gell, D., Smith, G. C., Zhang, H., Divecha, N., Connelly, M. A., Admon, A., Lees-Miller, S. P., Anderson, C. W., and Jackson, S. P. (1995). DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82, 849-856.
19. Joel, P. B., Traish, A. M., and Lannigan, D. A. (1995). Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol. Endocrinol. 9, 1041-1052.
20. Joel, P. B., Traish, A. M., and Lannigan, D. A. (1998). Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J. Biol. Chem. 273, 13317-13323.
21. Jope, R. S. and Johnson, G. V. (2004). The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95-102.
22. Ju, B. G., Lunyak, V. V., Perissi, V., Garcia-Bassets, I., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. (2006). A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 312, 1798-1802. (Pubitemid 43962898)
23. Kato, S. et al. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494.
24. Kysela, B., Chovanec, M., and Jeggo, P. A. (2005). Phosphorylation of linker histones by DNA-dependent protein kinase is required for DNA ligase IV-dependent ligation in the presence of histone H1. Proc. Natl. Acad. Sci. USA 102, 1877-1882.
25. Lannigan, D. A. (2003). Estrogen receptor phosphorylation. Steroids 68, 1-9.
26. Le Bail, J. C., Marre-Fournier, F., Nicolas, J. C., and Habrioux, G. (1998). C19 steroids estrogenic activity in human breast cancer cell lines: importance of dehydroepiandrosterone sulfate at physiological plasma concentration. Steroids 63, 678-683. (Pubitemid 29006374)
27. Lees-Miller, S. P. (1996). The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight. Biochem. Cell Biol. 74, 503-512.
28. Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E., and Anderson, C. W. (1992). Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12, 5041-5049.
29. Ma, H., Hill, C. K., Bernstein, L., and Ursin, G. (2008). Low-dose medical radiation exposure and breast cancer risk in women under age 50 years overall and by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res. Treat. 109, 77-90.
30. Mangelsdorf, D. J. et al. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
31. Martinez, E. and Wahli, W. (1989). Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity. EMBO J. 8, 3781-3791.
32. McDonnell, D. P. and Norris, J. D. (2002). Connections and regulation of the human estrogen receptor. Science 296, 1642-1644.
33. Medunjanin, S., Hermani, A., De Servi, B., Grisouard, J., Rincke, G., and Mayer, D. (2005). Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity. J. Biol. Chem. 280, 33006-33014.
34. Medunjanin, S., Weinert, S., Poitz, D., Schmeisser, A., Strasser, R. H., and Braun-Dullaeus, R. C. (2010). Transcriptional activation of DNA-dependent protein kinase catalytic subunit gene expression by oestrogen receptor-alpha. EMBO Rep. 11, 208-213.
35. Nawaz, Z., Lonard, D. M., Dennis, A. P., Smith, C. L., and O'Malley, B. W. (1999). Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA 96, 1858-1862.
36. Osborne, C. K. and Schiff, R. (2005). Estrogen-receptor biology: continuing progress and therapeutic implications. J. Clin. Oncol. 23, 1616-1622.
37. Reid, G., Hubner, M. R., Metivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J., and Gannon, F. (2003). Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 695-707.
38. Sadji, Z., Le, R. M., Lewin, M. J., and Reyl-Desmars, F. (2000). Human colon carcinoma cell-line HCT116 transfected by antisense cDNA as a tool to study the Ku86 involvement in cell proliferation. Cell Signal. 12, 745-750.
39. Stoica, G. E. et al. (2003a). Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene 22, 7998-8011.
40. Stoica, G. E., Franke, T. F., Wellstein, A., Czubayko, F., List, H. J., Reiter, R., Morgan, E., Martin, M. B., and Stoica, A. (2003b). Estradiol rapidly activates Akt via the ErbB2 signaling pathway. Mol. Endocrinol. 17, 818-830.
41. Wei, X., Xu, H., and Kufe, D. (2006). MUC1 oncoprotein stabilizes and activates estrogen receptor alpha. Mol. Cell 21, 295-305.
42. Weigel, N. L., Carter, T. H., Schrader, W. T., and O'Malley, B. W. (1992). Chicken progesterone receptor is phosphorylated by a DNA-dependent protein kinase during in vitro transcription assays. Mol. Endocrinol. 6, 8-14.
43. Zhu, C. and Roth, D. B. (1996). Mechanism of V(D)J recombination. Cancer Surv. 28, 295-309.